MAG
ABMD

Millrace Asset Group’s Abiomed Inc ABMD Stock Holding History

Millrace Asset Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,671
Closed -$1.85M – 94
2020
Q3 		$1.85M Buy
6,671
+1,300
+24% +$375K 1.49% 25
2020
Q2 		$1.3M Buy
+5,371
New +$1.08M 1.33% 38
2015
Q4 		– Sell
-3,648
Closed -$338K – 61
2015
Q3 		$338K Sell
3,648
-5,640
-61% -$497K 0.36% 52
2015
Q2 		$611K Sell
9,288
-2,724
-23% -$181K 0.64% 51
2015
Q1 		$859K Sell
12,012
-11,255
-48% -$611K 0.95% 44
2014
Q4 		$886K Buy
+23,267
New +$734K 0.92% 47

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millrace Asset Group's ABMD Position: Q4 2020 in Review

Millrace Asset Group sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 6,671 shares — an estimated $1.85M sold.

Millrace Asset Group first reported a position in ABMD in Q4 2014 and held it in 6 quarters. The position peaked at $1.85M in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Millrace Asset Group reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Millrace Asset Group sold 6,671 Abiomed Inc shares in Q4 2020, an estimated $1.85M.
  • Millrace Asset Group first reported a position in Abiomed Inc in Q4 2014 and held it in 6 quarters.
  • Millrace Asset Group's Abiomed Inc position peaked at $1.85M in Q3 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Millrace Asset Group's 13F filing for Q4 2020, filed 11 Feb 2021.